United Exchange Corp.April 6, 2018

FDA 483 - United Exchange Corp. - April 06, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore United Exchange Corp.

Record Details

An FDA inspection of United Exchange Corp., a pharmaceutical warehouse and importer in Rialto, CA, revealed two significant observations. The firm's sampling plan for incoming drug products was found to be unrepresentative and samples were not properly identified. Additionally, the facility lacked adequate segregation and identification methods for quarantined drug products, storing them alongside released products.

Company: United Exchange Corp.
Inspection Date: April 6, 2018
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Zachary A. Bogorad

Open in Dashboard

ID · db5e07f0-748d-42e6-b6fd-0e5afa6f7952